Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2019 - 06/30/2019

Lobbyist name	Geoffrey A Gallo
Business name	AstraZeneca Pharmaceuticals, LP
Address	3 Merles Lane
City, state, zip code	Stratham, NH 03885
Country	USA
Agent type	Both
Phone	603-770-9000

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: AstraZeneca Pharmaceuticals LP

Total amount paid by client; lobbyist is unable to report compensation at activity level: $25,500.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	915	An Act ensuring access to medications	Support	$0.00	N/A
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	N/A
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Support	$0.00	N/A
Senate Bill	614	An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications	Support	$0.00	N/A
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	N/A
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	N/A
House Bill	1168	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$0.00	N/A
House Bill	953	An Act relative to patient financial protection	Support	$0.00	N/A
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	N/A
Senate Bill	584	An Act limiting out of pocket health expenses	Support	$0.00	N/A
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
Senate Bill	733	An Act relative to consumer protection for prescription drug purchases	Neutral	$0.00	N/A
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	N/A
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Oppose	$0.00	N/A
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Neutral	$0.00	N/A
Senate Bill	570	An Act relative to out-of-pocket expenses for prescription drug coverage	Support	$0.00	N/A
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	N/A
House Bill	1933	An Act to improve patient access to cancer clinical trial programs	Neutral	$0.00	N/A
House Bill	949	An Act relative to non-medical switching	Support	$0.00	N/A
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	N/A
House Bill	969	An Act empowering health care consumers	Support	$0.00	N/A
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	N/A
Senate Bill	1352	An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth	Oppose	$0.00	N/A
House Bill	898	An Act relative to consumer deductibles	Support	$0.00	N/A
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	N/A
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	N/A
House Bill	1177	An Act relative to protecting health care consumers	Neutral	$0.00	N/A
House Bill	926	An Act relative to consumer deductibles	Support	$0.00	N/A
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	N/A
Senate Bill	721	An Act relative to mandatory prescription drug coverage	Oppose	$0.00	N/A
House Bill	1099	An Act to help patients and reduce health care costs by ensuring patient adherence to medications	Support	$0.00	N/A
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
Senate Bill	1701	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Oppose	$0.00	N/A
Senate Bill	561	An Act empowering health care consumers	Support	$0.00	N/A
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	N/A
House Bill	1186	An Act strengthening HPC and CHIA market oversight	Neutral	$0.00	N/A
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	N/A
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Neutral	$0.00	N/A
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	N/A
House Bill	3800	An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements	Oppose	$0.00	N/A
Senate Bill	717	An Act to create a special commission to improve transparency and affordability at the Group Insurance Commission	Oppose	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
01/14/2019	Jennifer Benson	State Representative	$200.00
01/18/2019	Joseph Boncore	State Senator	$200.00
03/05/2019	Julian Cyr	State Senator	$100.00
03/08/2019	Alice Hanlon Peisch	State Representative	$100.00
03/27/2019	John Lawn, Jr.	State Representative	$200.00
03/27/2019	Denise Garlick	State Representative	$200.00
03/31/2019	Hank Naughton	State Representative	$200.00
03/31/2019	Karen Spilka	State Senator	$200.00
03/31/2019	Thomas Stanley	State Representative	$100.00
04/11/2019	Ronald Mariano	State Representative	$200.00
04/22/2019	Nick Collins	State Senator	$200.00
04/29/2019	Jerald Parisella	State Representative	$200.00
04/29/2019	Bradley Jones	State Representative	$100.00
05/05/2019	Michael Rodrigues	State Senator	$200.00
05/05/2019	Diana DiZoglio	State Senator	$200.00
05/08/2019	John Mahoney	State Representative	$200.00
05/21/2019	Robert Deleo	State Representative	$200.00
06/18/2019	Patricia Haddad	State Representative	$200.00
06/19/2019	Timothy Whelan	State Representative	$200.00
06/19/2019	Democratic House PAC	State Representatives	$200.00
06/19/2019	Anne Margaret Ferrante	State Representative	$100.00
		Total contributions	$3,700.00

Close this page

Connect with Us